শুধুমাত্র তথ্যমূলক — চিকিৎসা পরামর্শ নয়। সর্বদা লাইসেন্সপ্রাপ্ত স্বাস্থ্যসেবা প্রদানকারীর পরামর্শ নিন।

MedBD
EN
Community data Updated 2 মাস আগে

ইঙ্গিত

Salazine is indicated in: Rheumatoid arthritis and juvenile arthritis: For the treatment of patients with rheumatoid arthritis, and of paediatric patients with polyarticular-course juvenile rheumatoid arthritis, who have responded inadequately to salicylates or other non-steroidal anti-inflammatory drugs (NSAIDs). Ulcerative colitis and Crohn's disease: As an adjunct in the treatment of ulcerative colitis, alongside the usual supportive and dietary measures. Also for the treatment of active Crohn's disease, especially in patients with colonic involvement.

⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।

ফার্মাকোলজি

The mode of action of Sulfasalazine is still under investigation, but may be related to the anti inflammatory and/or immunomodulatory properties that have been observed in animal and in vitro models, to its affinity for connective tissue, and/or to the relatively high concentration it reaches in serous fluids, the liver and intestinal walls, as demonstrated in autoradiographic studies in animals. In ulcerative colitis, clinical studies utilizing rectal administration of Sulfasalazine, Sulfapyridine and 5-Aminosalyclic Acid have indicated that the major therapeutic action may reside in the 5-Aminosalyclic Acid moiety. The relative contribution of the parent drug and the major metabolites in rheumatoid arthritis is unknown.

Pregnancy & Breastfeeding

Pregnancy category B. This drug should only be used during pregnancy if it is clearly needed. Caution should be exercised when giving sulfasalazine to a nursing mother.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

ডোজ নির্দেশিকা

⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।

Adults: The dose of Sulfasalazine tablets should be adjusted for each patient according to how well the treatment is tolerated and how the patient responds. Doses should be evenly spaced through the day and are best taken after meals. For Crohn's disease, the adult dose is 500 mg by mouth 2 to 4 times a day with food. Pediatric use (6 years or older) for ulcerative colitis: the initial dose is 40 to 60 mg/kg/day by mouth, divided into 3 to 6 doses. For rheumatoid arthritis, the adult dose is 2 g daily in two evenly divided doses. It is advisable to begin treatment at a lower dose, for example 0.5 to 1.0 g daily, to reduce the chance of stomach and bowel upset. A suggested dosing schedule is as follows: in the first week, one tablet in the evening; in the second week, one tablet in the morning and one tablet in the evening; in the third week, one tablet in the morning and two tablets in the evening; in the fourth week, two tablets in the morning and two tablets in the evening. For children 6 years or older, the initial dose is 10 mg/kg/day by mouth in 2 equally divided doses. For juvenile rheumatoid arthritis with a polyarticular course, children 6 years of age and older receive 30 to 50 mg/kg/day in two evenly divided doses; the maximum dose is typically 2 g per day. For other indications, initial therapy in adults is 3 to 4 g daily in divided doses, with no more than eight hours between doses. It may be advisable to begin at a lower dose, for example 1 to 2 g daily, to reduce the chance of stomach and bowel upset. Children 6 years of age and older receive 40 to 60 mg/kg/day in 3 to 6 divided doses. For maintenance therapy, adults take 2 g daily, and children 6 years of age and older take 30 mg/kg/day in 4 divided doses.

পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া

পার্শ্বপ্রতিক্রিয়া

No side-effect data recorded yet.

প্রধান পারস্পরিক ক্রিয়া

Checker →